BSE filing, NSE: DHINDIA. Summary written from the filing by ALFA Finder's alert engine.
D & H India Ltd: key numbers
- Share price
- ₹160.00
- Market cap
- ₹163.8 Cr
- Revenue (annual)
- ₹252.7 Cr
- Net profit (annual)
- ₹8.38 Cr
- P/E (TTM)
- 19.7×Sector 52.2×
- Promoter holding
- 44.86%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from D & H India Ltd
All →D & H India Convertible Warrants
D&H India Limited withdrew its proposed preferential issue of 21,57,000 warrants, citing delays. Future funding will be sourced via internal accruals and bank borrowings.
- Value
- ₹32.57 Cr
D & H India Other Announcement
D & H India Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
D & H India Board Meeting Date
D & H India announced a board meeting on October 15, 2026, to discuss an update on its ongoing preferential issue of 2,157,000 warrants.
D & H India Management Change
D & H India Limited announced the re-appointment of Saurabh Vora and Harsh Vora as Executive Directors for a 36-month term effective October 1, 2026.
D & H India Annual General Meeting
D & H India Limited conducted its 41st Annual General Meeting on 30th September 2026. The meeting covered routine procedural agenda items, including financial statements and director re-appointments.
D & H India Acquisition Worth ₹18 Cr
D & H India Ltd is acquiring leasehold industrial land in Indore for Rs. 18 Crore. This material asset purchase supports the company's long-term expansion strategy.
- Value
- ₹18.00 Cr
- industrial land area
- 70094.0 Square Meter
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.